Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/46662a33a2a04b4e89ceddf01ba602a9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:46662a33a2a04b4e89ceddf01ba602a9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:46662a33a2a04b4e89ceddf01ba602a92021-11-16T09:00:05ZQuantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer10.1136/jitc-2020-0021002051-1426https://doaj.org/article/46662a33a2a04b4e89ceddf01ba602a92021-02-01T00:00:00Zhttps://jitc.bmj.com/content/9/2/e002100.fullhttps://doaj.org/toc/2051-1426Leisha A EmensHuilin MaHanwen WangRichard J SovéAleksander S PopelBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Leisha A Emens Huilin Ma Hanwen Wang Richard J Sové Aleksander S Popel Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
format |
article |
author |
Leisha A Emens Huilin Ma Hanwen Wang Richard J Sové Aleksander S Popel |
author_facet |
Leisha A Emens Huilin Ma Hanwen Wang Richard J Sové Aleksander S Popel |
author_sort |
Leisha A Emens |
title |
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
title_short |
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
title_full |
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
title_fullStr |
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
title_full_unstemmed |
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
title_sort |
quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
publisher |
BMJ Publishing Group |
publishDate |
2021 |
url |
https://doaj.org/article/46662a33a2a04b4e89ceddf01ba602a9 |
work_keys_str_mv |
AT leishaaemens quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer AT huilinma quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer AT hanwenwang quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer AT richardjsove quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer AT aleksanderspopel quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer |
_version_ |
1718426600124448768 |